Topical Minoxidil Reported Hair Discoloration: A Cross-Sectional Study

Minoxidil may inhibit androgen receptors and affect hormonal pathways, potentially explaining its effectiveness in treating androgenetic alopecia (AGA). Users discuss its varying effectiveness on scalp versus facial hair and note fewer side effects with topical use compared to oral.

A 23-year-old male uses minoxidil and finasteride daily for androgenetic alopecia and is concerned about dandruff, which a dermatologist addressed with two serums. He uses ketoconazole shampoo twice a week to manage scalp issues.

A 21-year-old was diagnosed with early-stage androgenetic alopecia and prescribed only minoxidil 5% and ketoconazole shampoo by a dermatologist, who advised against finasteride for now. The user is skeptical about starting minoxidil due to concerns about increased hair loss.

A user is starting a hair loss treatment with Minoxidil (5 mg oral and 10% topical), Dutasteride, and Zinc, and is concerned about the high dosages. Other users suggest following the dermatologist's advice, starting with topical treatments, and discussing dosage concerns with the doctor.

The user is using minoxidil, topical finasteride, Nizoral shampoo, and a dermaroller for hair regrowth but is experiencing changes in sexual function. They are concerned about whether these changes are due to the treatment and are seeking advice on continuing hair growth without affecting sexuality.

A 37-year-old is using topical Minoxidil once daily to address hair thinning, avoiding finasteride due to regular blood donations. They are satisfied with the results, seeing new hair growth, and prioritize blood donation over additional treatments.